Chemohormonal Therapy Effective in Metastatic Prostate Cancer CME/CE

: A randomized study shows that docetaxel from the start, alongside androgen deprivation therapy, improves survival outcomes in a new study of men with advanced hormone-sensitive prostate cancer.